Czech and Slovak Ophthalmology 70 10.31348/2018/1/2-2-2018 Original article Use of micropulse laser in patients with diabetic macular edema at the department of ophthalmology, university hospital Hradec Králové Veselá Šárka Hejsek Libor https://orcid.org/0000-0001-9973-8969 Stěpanov Alexandr https://orcid.org/0000-0002-8462-8756 Dusová Jaroslava Marák Jan Jirásková Naďa Studnička Jan https://orcid.org/0000-0002-9911-4379 23 8 2018 2 2

Introduction: Diabetic macular edema (DME) is the most frequent cause of decreased vision in patiens with diabetes type 2. DME is caused by increased permeability of macular capillaries. The aim of our study was to retrospectively evaluate the results of micropulse laser treatment, 577 nm wavelength, in pacients with DME with follow-up three months and one year. Methods: The retrospective trial with one year follow-up includes 63 eyes of 37 patients with diabetic macular edema treated from September 2015 to January 2017. Most patients had diabetes type 2 (34 patients), 3 patients had diabetes type 1. Diffuse DME was diagnosed in 54 eyes, focal DME in 9 eyes. Most of the patients (42 eyes) suffered from non proliferative diabetic retinopathy, 21 eyes showed signs of proliferative retinopathy. DME lasted on average for 29 months before initiating with micropulse laser (median 21 months). On average 1,56 laser visits were needed for the treatment of 1 eye, usually in 3 months interval. Photocoagulation of macula was performed in all patients by micropulse laser, 577 nm wavelenght/IQ 577TM IRIDEX). We used 5 % duty cycle. The average glycated hemoglobin in the group was 66,8 mmol/mol, maximal 100 mmol/mol. Estimated data were statistically evaluated by Friedman and Dunn´s test. Results: At the end of 1 year period we found out improvement in BCVA (increase of at least 5 letters of ETDRS charts) in 20 eyes, 25 eyes showed stabilisation of BCVA (alltogether 71 % of the group), in 18 eyes we found out decrease of BCVA of more than 5 letters of ETDRS charts. On average we estimated decrease of visual acuity from 62 to 61,1 letters (p > 0,05). After one year we estimated 63 μm CRT decrease on average, from 442 μm to 379 μm (p= 0,0124). Conclusion: In our group of DME patiens treated by micropulse laser we have estimated BCVA stabilisation and signifiant improvement of macular edema in ¾ eyes, confirmed by OCT. We have estimated clinically significant decrease of macular edema in the whole group with one-year follow-up.

 micropulse laser diabetic macular edema optical coherence tomography central retinal thickness laser retinal photocoagulation References Das et al.: Diabetic macular edema: Pathophysiology and novel therapeutictargets. Ophthalmology 2015;122:1375-94. Diabetic Retinopathy Clinical Research Network: A randomized trial comparing intravitreal trimacinolon eacetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 115:1447-1459. Early Treatment DiabeticRetinopathy Study Research Group: Photocoagulation for diabetic macular edema. Early Treatment DiabeticRetinopathy Study report number 1. Arch Ophthalmol 1985 Dec; 103(12):1796-806. Feistmann, JA., Rosenthal, JL.:.Making the Jump to Micro Pulse Laser Therapy for Treating theMacule, An effective first-line therapy adjunct to current ttreatments. Micro Pulse safely treats areas tion for diabetic macular oedema. Eye (London); 2010: 24:784–788. Kahn, HA., Bradley, RF.: Prevalence of diabetic retinopathy. Age, sex, and duration of diabetes. Br J Ophthalmol 1975;59: 345–9 Kahn, HA., Hiller, R.: Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974; 78:58–67. Lavinsky, D., Cardillo, JA., Melo, LA. et al.: Randomized clinical trial evaluating ETDRS versus normalorhigh-density micropulse photocoagulation for diabetic macular edema. Invest Ophthalmol Vis Sci.; 2011:52: 4314–4323. Nakamuram, Y., Mitamura, Y., Ogata, K. et al.: Functional and morphological ganges of macula after subthreshold micropulse diode laser photocoagula- Sipravasad, S., Elagouz, M., McHugh, D. et al.: Micropulsed diode laser therapy:Evolution and clinical applications, Survey Ophthalmol, November–December; 2010: 55 (6): 516–530. Stanga, PE., Reck, AC., Hamilton, AMP. et al.: Micropulse laser in thetreatment of diabetic macular edema, Semin Ophthamol; 1999: 14(4): 210-213. Yoon, HK., Dong, KL., Oh, W K., et al.: The Short-term Efficacy of Subtreshold MicropulseYellow (577-nm) Laser Photocoagulation for Diabetic MacularEdema, Korean J Ophthalmol.; 2014: 28(5): 379–385. Závorková, M., Procházková, L.: Léčba diabetického makulárního edému mikropulzním laserem – první zkušenosti. Ces Slov Oftalmol; 2015: 71(5):223-228.